Literature DB >> 8578239

Individualized acute treatment strategies for gastroesophageal reflux disease.

J C Reynolds1.   

Abstract

Although gastroesophageal reflux disease is among the most common disorders seen by gastroenterologists, the wide variation in both its symptoms and severity has led to a lack of consensus about the most appropriate practical approach to treatment of patients with acute symptoms. This review considers the efficacy of the most widely used pharmacologic agents in the acute treatment of gastroesophageal reflux disease: H2-receptor antagonists, proton-pump inhibitors, and prokinetic agents. Possible treatment strategies in which they may be used are discussed and it is proposed that individualized treatment strategies should be developed based on symptoms and severity of disease. Emphasis is placed on the fact that, given the wide variety of effective agents available, the use of the same agent in every patient, regardless of their symptoms, is a most inappropriate approach. A stepwise approach to therapy utilizing a number of drug classes is discussed and the rationale for and appropriate use of both a 'step-up' and 'step-down' approach is considered.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8578239

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  5 in total

1.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

2.  An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.

Authors:  S J Veldhuyzen van Zanten; N Flook; N Chiba; D Armstrong; A Barkun; M Bradette; A Thomson; F Bursey; P Blackshaw; D Frail; P Sinclair
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

3.  Efficacy of Lafutidine Versus Famotidine in Patients with Reflux Esophagitis: A Multi-Center, Randomized, Double-Blind, Non-inferiority Phase III Trial.

Authors:  Eun Hye Kim; Yong Chan Lee; Young Woon Chang; Jong-Jae Park; Hoon Jai Chun; Hwoon-Yong Jung; Hyun-Soo Kim; Hyun Yong Jeong; Sang-Young Seol; Sok Won Han; Myung-Gyu Choi; Soo-Heon Park; Ok-Jae Lee; Jin Tae Jung; Dong Ho Lee; Hyun Chae Jung; Soo Teik Lee; Jae Gyu Kim; Sei Jin Youn; Hak Yang Kim; Sang Woo Lee
Journal:  Dig Dis Sci       Date:  2014-12-23       Impact factor: 3.199

Review 4.  Medical treatment of gastro-oesophageal reflux disease.

Authors:  F De Giorgi; M F Savarese; E Atteo; C A Leone; R Cuomo
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-10       Impact factor: 2.124

5.  "Proton-pump inhibitor-first" strategy versus "step-up" strategy for the acute treatment of reflux esophagitis: a cost-effectiveness analysis in Japan.

Authors:  Yasuki Habu; Kazuo Maeda; Takeo Kusuda; Takuya Yoshino; Seiji Shio; Maki Yamazaki; Takanobu Hayakumo; Kyohei Hayashi; Yoshiyuki Watanabe; Keiichi Kawai
Journal:  J Gastroenterol       Date:  2005-11       Impact factor: 6.772

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.